NYSE:MLSS
Milestone Scientific Inc.
Milestone Scientific Inc.'s revenue grew 4.0% in fiscal 2025 to $9.0M while operating margin rose to −63.5%. Free cash flow was −$2.9M, −32.7% of revenue, and the diluted share count rose 2.8%.Summary generated from Milestone Scientific Inc.'s SEC filings. Latest annual report filed Mar 31, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$9.0M
Revenue growth+4.0%
Revenue, 5-yr CAGR+10.5%
Gross margin71.4%
Operating margin−63.5%
Net margin−63.8%
ROICn/a
Return on equity−132.4%
Debt / equityn/a
Free cash flow−$2.9M
FCF margin−32.7%
Share count change+2.8%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 10 | 9 | 10 | 9 | 9 |
| Operating income | −7 | −9 | −7 | −7 | −6 |
| Net income | −7 | −9 | −7 | −5 | −6 |
| Free cash flow | −4 | −6 | n/a | −3 | −3 |
Recent filings
- 10-QQuarterly report for the period ended Jun 30, 2026
Aug 13, 2026 - 8-KDirector or officer change
Jul 31, 2026 - 8-KOther events
Jul 29, 2026 - 8-KEntry into a material agreement
Jun 25, 2026 - DEF 14AProxy statement
Jun 22, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 13, 2026 - 8-KChange in auditor
May 6, 2026 - 8-KDirector or officer change
May 6, 2026